For so long, new tools in the evaluation and treatment of epilepsy have been field tested in adults and extrapolated to benefit children. Genetic testing is the pediatric equivalent of paying it forward. Adults with epilepsy of unknown cause deserve the same opportunities as children when it comes to molecular diagnosis and stand to benefit from the same advances in treatment. So, put away the white flag and continue looking for answers in those without one.